food and beverage brandReviewed profile

Actos

Retail brand

Public category
Retail brand
Products tracked
1
Brand tier
mainstream brand
Headquarters
Japan
Is this your company?Claim Actos to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Actos — no cold outreach.
Report a changeLog in for full recordLast reviewed 1 Aug 2026

Overview

What Actos covers.

Actos is a prescription medication containing pioglitazone, utilized primarily to improve glycemic control in adults with type 2 diabetes mellitus. Developed and marketed by Takeda Pharmaceutical Company, the drug belongs to the thiazolidinedione class and functions by increasing insulin sensitivity in muscle and adipose tissue. It is prescribed for patients seeking to manage their blood glucose levels as an adjunct to diet and exercise.

  • Talio tracks 1 product for Actos.
  • Positioned as a mainstream brand.
  • Headquartered in Japan.

FAQ

Questions this page answers.

What does Actos do?

Actos is a food and beverage brand based in Japan, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Proprietary metrics remain in authenticated Talio.